|
| Exchange Disseminated Time 20/10/2015 15:09:53 | Jubilant Life Sciences Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on October 29, 2015, inter-alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended September 30, 2015 (Q2).
Further, as per the Company’s Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company would remain closed for the Designated Persons of the Company from October 22, 2015 to October 31,2015 (both days inclusive). |
|
|